tiprankstipranks
Trending News
More News >
BridgeBio Pharma: Promising Outlook with Strong Execution and Growth Potential
PremiumRatingsBridgeBio Pharma: Promising Outlook with Strong Execution and Growth Potential
26d ago
BridgeBio announces first participant dosed with acoramidis in ACT-EARLY
Premium
The Fly
BridgeBio announces first participant dosed with acoramidis in ACT-EARLY
29d ago
Chord, InMode, Upstart, BridgeBio, Astria: Trending by Analysts
Premium
Weekend Updates
Chord, InMode, Upstart, BridgeBio, Astria: Trending by Analysts
1M ago
BridgeBio Pharma’s Earnings Call Highlights Success and Growth
PremiumCompany AnnouncementsBridgeBio Pharma’s Earnings Call Highlights Success and Growth
1M ago
BridgeBio price target raised to $55 from $52 at Scotiabank
Premium
The Fly
BridgeBio price target raised to $55 from $52 at Scotiabank
1M ago
BridgeBio price target raised to $72 from $65 at UBS
Premium
The Fly
BridgeBio price target raised to $72 from $65 at UBS
1M ago
BridgeBio Pharma Reports Q1 2025 Earnings and Pipeline Progress
PremiumCompany AnnouncementsBridgeBio Pharma Reports Q1 2025 Earnings and Pipeline Progress
1M ago
BridgeBio reports Q1 EPS (88c), consensus ($1.00)
Premium
The Fly
BridgeBio reports Q1 EPS (88c), consensus ($1.00)
1M ago
BridgeBio Pharma options imply 8.2% move in share price post-earnings
Premium
The Fly
BridgeBio Pharma options imply 8.2% move in share price post-earnings
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100